1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Emerging Respiratory Pathogen Grant" is currently closed and not accepting applications.
Emerging Respiratory Pathogen Grant is sponsored by Independent, self-directed investigators with a strong research record and the potential to advance knowledge about respiratory viruses that could cause epidemics. The Emerging Respiratory Pathogen Grant provides funding for independent investigators researching the biology, transmission, epidemiology, and short- and long-term health effects of respiratory infections.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Emerging Respiratory Pathogen Award by American Lung Association 2026 | Atom Grants Emerging Respiratory Pathogen Award The Emerging Respiratory Pathogen Award from the American Lung Association funds innovative research into the biology, spread, and long-term effects of respiratory infections and pathogens.
Funder: American Lung Association Due Dates: September 18, 2026 (LOI) | December 1, 2026 (Full application) Funding Amounts: $100,000 per year for up to two years (maximum $200,000 total) Summary: Supports innovative research on the biology, epidemiology, and long-term impacts of respiratory infections, including emerging and established pathogens.
Key Information: Letter of Intent required; only one application/LOI per applicant per cycle; U.S. nonprofit institutions only. The American Lung Association's Emerging Respiratory Pathogen Award funds independent investigators aiming to advance understanding of respiratory infections, including both known and novel pathogens.
The award supports clinical, basic, translational, and population health research that explores viral mechanisms, host responses, community spread, and the pathophysiology of long-term sequelae (such as those seen in COVID-19). The goal is to drive innovation in the prevention, diagnosis, and treatment of respiratory diseases. Proposals related to gain-of-function research are not accepted.
See the full grant listing
According to the current listing, eligibility includes: Independent, self-directed investigators with a strong research record and the potential to advance knowledge about respiratory viruses that could cause epidemics, affiliated with a nonprofit scientific or educational i…. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 per year, up to 2 years (potential total award up to $200,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 10, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Emerging Respiratory Pathogen Grant is funded by Independent, self-directed investigators with a strong research record and the potential to advance knowledge about respiratory viruses that could cause epidemics. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NSF Tech Labs initiative will fund independent research organizations with $10-50M annually on milestone-based contracts. A deep analysis of the biggest structural shift in NSF funding in decades.
Read articleNIH obligated $2.2 billion across more than 2,000 multiyear-funded grants in FY2025, six percent of all extramural obligations. Through mid-May FY2026, the pattern has accelerated — 601 grants and $402 million already obligated versus 162 grants and $79 million at the same point a year earlier. The crowding-out effect on new R01 competition is now measurable, and Congress has imposed a cap. Here's what's happening and what investigators should plan around.
Read articleNSF just committed $380 million to build a national network of AI-programmable, remotely operated laboratories — the Programmable Cloud Laboratories Test Bed (NSF 25-541), the agency's flagship contribution to the Genesis Mission. Twenty nodes, four years, self-driving experiments in chemistry, biology and materials. Here is what it funds, who is eligible, why the 'existing facilities only' rule matters, and how researchers and companies should position for what comes next.
Read article